Eric S. Fischer
- Molecular Biology top 1%
- Oncology top 1%
- Hematology top 0.5%
- Immunology top 5%
- Organic Chemistry top 5%
- Co-authors
- Katherine A. DonovanNathanael S. GrayRadosław P. NowakNicolas H. ThomäTinghu ZhangGeorg PetzoldBenjamin L. EbertBaishan Jiang
- Topics
- Protein Degradation and Inhibitors (79 papers)Ubiquitin and proteasome pathways (63 papers)Peptidase Inhibition and Analysis (18 papers)
- Cited by
- HematologyMolecular BiologyOncology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Eric S. Fischer
111 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Biology 6.0k
- Oncology 2.3k
- Hematology 1.3k
- Immunology 437
- Organic Chemistry 339
Countries citing papers authored by Eric S. Fischer
This map shows the geographic impact of Eric S. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Fischer more than expected).
Fields of papers citing papers by Eric S. Fischer
This network shows the impact of papers produced by Eric S. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Fischer. The network helps show where Eric S. Fischer may publish in the future.
Co-authorship network of co-authors of Eric S. Fischer
This figure shows the co-authorship network connecting the top 25 collaborators of Eric S. Fischer. A scholar is included among the top collaborators of Eric S. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric S. Fischer. Eric S. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 12 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 26 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 54 | |
| 11 | 8 | |
| 12 | 67 | |
| 13 | 0 | |
| 14 | 4 | |
| 15 | 26 | |
| 16 | 34 | |
| 17 | 9 | |
| 18 | 2 | |
| 19 | 203 | |
| 20 | Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation | 1 |
About Eric S. Fischer
Eric S. Fischer is a scholar working on Hematology, Molecular Biology and Oncology, having authored 118 papers that have together received 6.7k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (79 papers), Ubiquitin and proteasome pathways (63 papers) and Peptidase Inhibition and Analysis (18 papers). The work is most often cited by research in Hematology (1.3k citations), Molecular Biology (6.0k citations) and Oncology (2.3k citations). Eric S. Fischer has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Katherine A. Donovan, Nathanael S. Gray, Radosław P. Nowak, Nicolas H. Thomä, Tinghu Zhang, Georg Petzold, Benjamin L. Ebert, Baishan Jiang, Eric S. Wang and James E. Bradner. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.